 comparison sucralf placebo treatment esophag ulcer therapeut endoscop sclerotherapi esophag varic prospect random trial roark first report sucralf treatment esophag ulcer sclerotherapi uncontrol trial prospect double-blind placebo-control studi patient therapeut paravaric injection-sclerotherapi esophag varic patient sucralf suspens placebo time treatment maximum week dosag sucralf q.i.d ulcogant-suspens endoscopi weekli interv fifty-thre patient sucralf placebo evalu protocol patient studi side effect start trial patient sucralf group ulcer area placebo group tendenc sucralf group patient deeper ulcer signific differ global heal treatment group week sucralf suspens valu process esophag ulcer sclerotherapi patient deep ulcer result trial patient respect ulcer volum sever liver diseas